Back

VANISH Trial Results

27 August 2021 (10:30 - 10:45)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Carolyn Ho

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

2 More presentations in this session

Presentation thumbnail
AVANTI: Dual VP-receptor Antagonism in HF
Professor J. Udelson (Boston, US)
Slides Video
Presentation thumbnail
DAPA-HF
Doctor J. Curtain (Dublin, IE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Reduction in shock burden with catheter ablation versus escalated antiarrhythmic drug therapy: Insights from the VANISH trial
3 April 2022
thumbnail
Congress Presentation
External applicability of blood pressure-lowering drug trials to real-world patients with manifest cardiovascular disease
28 August 2020
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025
thumbnail
Congress Presentation
Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources